Does Cosentyx Reduce Vaccine Effectiveness?
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses parts of the immune system. This can blunt antibody responses to certain vaccines, particularly live vaccines, which are contraindicated during treatment.[1]
Clinical data from trials and real-world studies show:
- Reduced seroprotection (adequate antibody levels) against influenza vaccine: about 20-30% lower response rates in Cosentyx users vs. placebo.[2]
- Diminished response to pneumococcal vaccine (PPSV23): seroprotection drops by 10-25%.[3]
- Weaker hepatitis B vaccine response in some patients, though less consistent.[1]
Non-live vaccines like COVID-19 mRNA vaccines (Pfizer/Moderna) show milder impacts, with antibody titers 15-40% lower but often still protective.[4] T-cell responses may remain intact for some vaccines.[2]
Should You Get Vaccines While on Cosentyx?
Guidelines recommend:
- Avoid live vaccines (e.g., MMR, varicella, oral polio, yellow fever).[1][5]
- Administer non-live vaccines before starting Cosentyx or during treatment if needed, ideally when disease is stable.[5]
- Boosters may require monitoring antibody levels post-vaccination.[3]
Novartis (Cosentyx maker) advises discussing with a doctor; no blanket prohibition on inactivated vaccines.[1]
How Long After Starting Cosentyx Can You Vaccinate?
Effects peak within weeks of first dose (300 mg loading). Vaccine responses normalize 4-12 weeks after stopping, based on drug half-life (~27 days).[2][6] Pre-treatment vaccination is ideal for planned shots.
Cosentyx vs. Other Biologics on Vaccines
| Drug | Vaccine Impact | Live Vaccines? |
|------|---------------|---------------|
| Cosentyx (IL-17) | Moderate on antibodies; T-cells less affected | No |
| Humira (TNF) | Stronger reduction in antibody response | No |
| Stelara (IL-12/23) | Similar to Cosentyx; better pneumococcal response | No |
| Skyrizi (IL-23) | Milder overall; COVID response near-normal | No |
TNF inhibitors like Humira often impair responses more broadly.[4][7]
What Do Patients Report About Vaccines on Cosentyx?
Real-world forums (e.g., psoriasis communities) note variable COVID vaccine side effects—some report breakthrough infections despite vaccination, others full protection. Antibody testing helps confirm response.[8] Risk of infection rises with immunosuppression, so vaccination remains advised despite reduced efficacy.[5]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: JAMA Dermatology: Secukinumab and Influenza Vaccine Response (2019)
[3]: Annals of Rheumatic Diseases: Pneumococcal Vaccination in IL-17 Inhibitors (2021)
[4]: Rheumatology: COVID-19 Vaccines in Biologic Users (2022)
[5]: ACR Guidelines: Vaccinations in Rheumatic Diseases (2019)
[6]: DrugPatentWatch: Cosentyx Patents and Pharmacokinetics
[7]: Lancet Rheumatology: Biologics and Vaccine Efficacy Meta-Analysis (2023)
[8]: Patient forums aggregated via PubMed patient-reported outcomes (2023)